Wells Fargo & Company MN reduced its position in HealthSouth Corp (NYSE:HLS) by 12.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 975,410 shares of the company’s stock after selling 143,312 shares during the period. Wells Fargo & Company MN owned about 0.99% of HealthSouth worth $45,210,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in HLS. Advisor Group Inc. boosted its holdings in shares of HealthSouth by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after purchasing an additional 781 shares during the period. Aviva PLC boosted its holdings in shares of HealthSouth by 67.5% during the second quarter. Aviva PLC now owns 43,670 shares of the company’s stock worth $2,133,000 after purchasing an additional 17,600 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in shares of HealthSouth by 5.3% during the second quarter. Schwab Charles Investment Management Inc. now owns 671,304 shares of the company’s stock worth $32,492,000 after purchasing an additional 34,035 shares during the period. Prudential Financial Inc. boosted its holdings in shares of HealthSouth by 137.1% during the second quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock worth $21,039,000 after purchasing an additional 251,372 shares during the period. Finally, Great Lakes Advisors LLC boosted its holdings in shares of HealthSouth by 22.1% during the second quarter. Great Lakes Advisors LLC now owns 26,480 shares of the company’s stock worth $1,282,000 after purchasing an additional 4,796 shares during the period. 93.37% of the stock is currently owned by institutional investors and hedge funds.
HealthSouth Corp (NYSE HLS) traded down $0.15 during midday trading on Monday, reaching $49.21. 586,700 shares of the company’s stock were exchanged, compared to its average volume of 902,335. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. The firm has a market capitalization of $4,837.88, a PE ratio of 17.64, a PEG ratio of 1.81 and a beta of 0.54. HealthSouth Corp has a 1 year low of $38.24 and a 1 year high of $50.41.
HealthSouth (NYSE:HLS) last posted its earnings results on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. The firm had revenue of $995.60 million during the quarter, compared to analysts’ expectations of $985.75 million. HealthSouth had a net margin of 6.69% and a return on equity of 22.81%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.65 earnings per share. analysts expect that HealthSouth Corp will post 2.72 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Tuesday, January 2nd will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date is Friday, December 29th. HealthSouth’s dividend payout ratio (DPR) is presently 36.36%.
In other HealthSouth news, Director Yvonne M. Curl bought 1,000 shares of HealthSouth stock in a transaction on Wednesday, November 1st. The stock was purchased at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the purchase, the director now directly owns 64,144 shares of the company’s stock, valued at $2,947,416.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is owned by insiders.
Several analysts recently commented on HLS shares. Zacks Investment Research cut shares of HealthSouth from a “buy” rating to a “hold” rating in a report on Tuesday, August 15th. Stephens started coverage on shares of HealthSouth in a report on Thursday, August 31st. They set an “overweight” rating and a $53.00 price target for the company. ValuEngine cut shares of HealthSouth from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Royal Bank Of Canada restated a “buy” rating and set a $55.00 price target on shares of HealthSouth in a report on Wednesday, September 6th. Finally, KeyCorp restated a “hold” rating on shares of HealthSouth in a report on Thursday, September 7th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $51.75.
TRADEMARK VIOLATION WARNING: This piece was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://ledgergazette.com/2017/12/11/wells-fargo-company-mn-has-45-21-million-stake-in-healthsouth-corp-hls.html.
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp (NYSE:HLS).
Receive News & Ratings for HealthSouth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp and related companies with MarketBeat.com's FREE daily email newsletter.